Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR). https://gardp.org/this-is-big/https://bsky.app/profile/gardp.bsky.socialhttps://bsky.app/profile/gardp.bsky.social/post/3mvmhv7nbtc2z1 WEEK TO GO | #GAMRIC2026 🗓️22–24 Sept 2026 📍Lisbon, Portugal In one week, researchers, academics and industry experts from around the world will meet at the 2nd Global AMR Innovators Conference (GAMRIC) 2026 to explore innovations addressing #AMR. 🔗Register now: https://www.gamric.org/registration-travel-grants/16 Sep 2026 06:06 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mvmhv7nbtc2zhttps://bsky.app/profile/gardp.bsky.social/post/3mvjy3auqts2d#FungalAwarenessWeek2026 | 2 days to go! Join #REVIVE on 17 Sept for our webinar exploring newer azoles, extended dosing, long half-life echinocandins and novel antifungals, with a live Q&A. https://attendee.gotowebinar.com/register/754048829754636117?source=Bluesky15 Sep 2026 06:17 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mvjy3auqts2dhttps://bsky.app/profile/gardp.bsky.social/post/3mvhg6rbacs2eNewly published GARDP-sponsored research offers encouraging evidence for expanding treatment options for newborns with sepsis. 🔗 pubmed.ncbi.nlm.nih.gov/42705380/ #AMR #GARDP https://pubmed.ncbi.nlm.nih.gov/42705380/14 Sep 2026 05:52 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mvhg6rbacs2ehttps://bsky.app/profile/gardp.bsky.social/post/3mveyjd4x6s2tOn #WorldSepsisDay, we’re reminded that treating sepsis depends on having antibiotics that work. As resistance grows, those options are shrinking. “Invest in Sepsis – Save Lives” means investing in the treatments we need to stay ahead. #AMRIsBig #OurResponseIsBigger13 Sep 2026 06:42 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mveyjd4x6s2thttps://bsky.app/profile/gardp.bsky.social/post/3mva7atxhl224In Germany, earlier diagnosis helps patients receive treatment for sepsis sooner, but AMR is making infections harder to treat. Peter Beyer writes in Tagesspiegel Background on why sepsis investment must include new antibiotics: tinyurl.com/3pt7tama #WorldSepsisDay #AMRIsBig #OurResponseIsBigger https://gardp.org/sepsis-a-race-against-time-and-against-resistance/11 Sep 2026 08:59 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mva7atxhl224https://bsky.app/profile/gardp.bsky.social/post/3mv7vluj6hc26Personalized phage therapy has strong biological promise. But making it part of routine #AMR care will depend on stronger infrastructure. A new #REVIVE viewpoint explores what it will take to scale. 🔗https://tinyurl.com/53y2pf5411 Sep 2026 06:06 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mv7vluj6hc26https://bsky.app/profile/gardp.bsky.social/post/3mv33a2ayek2m💻 Register for #REVIVE’s 29 Sept webinar on clinical trial evidence shaping antibiotic use. ⏰29 Sept | 13:30 - 15:00 CEST https://attendee.gotowebinar.com/register/2615671549442631512?source=Bluesky @jesusrbano.bsky.social I @clarityinitiative.bsky.social09 Sep 2026 08:04 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mv33a2ayek2mhttps://bsky.app/profile/gardp.bsky.social/post/3muyu3nx6zs2kSTARTING 🔜 Join the #WorldSepsisDay webinar exploring how neonatal antimicrobial stewardship can improve antibiotic use today and help protect treatment options for tomorrow. GARDP’s Justin Green will be joining the expert discussion. [contains quote post or other embedded content]08 Sep 2026 10:51 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3muyu3nx6zs2khttps://bsky.app/profile/gardp.bsky.social/post/3muypb4zfns2uNew in @thelancet.com: the PediCAP trial brings important evidence on treating severe community-acquired pneumonia in young children in African hospitals. The trial used a novel design to examine IV-to-oral antibiotic step-down, antibiotic choice and more. 🔗 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00879-2/fulltext08 Sep 2026 09:24 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3muypb4zfns2uhttps://bsky.app/profile/gardp.bsky.social/post/3muwt52jha22aJournalist Md Zahid Hossain Khan investigates AMR in Bangladesh’s ICUs and NICUs in a new Daily Sun feature. The story is part of GARDP’s first-ever #WithoutBordersMediaFellowship, supporting in-depth AMR reporting across South Asia. 🔗Read the full article here: https://www.daily-sun.com/health/896409/the-reign-of-superbugs-in-bangladesh-s-icus-and-nicus-a-silent-p07 Sep 2026 15:28 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3muwt52jha22ahttps://bsky.app/profile/gardp.bsky.social/post/3muojrn5ouc26What does a new antibiotic have to do with sexual health? More than you might think. As gonorrhoea becomes harder to treat, impact can reach reproductive health, pregnancy and newborns. That makes antibiotic innovation part of sexual health. 🦠 #AMRIsBIG #OurResponseIsBIGGER04 Sep 2026 08:19 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3muojrn5ouc26https://bsky.app/profile/gardp.bsky.social/post/3mujbxdtxec2r📅 Save the date: 9–11 Feb 2027 The #ACC2027 is a free, open-access virtual conference, jointly organised by @bsacandjac.bsky.social and GARDP within the framework of the @eupohamr.bsky.social. More info coming soon! 🌐Explore the website: acc-conference.com02 Sep 2026 06:16 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mujbxdtxec2rhttps://bsky.app/profile/gardp.bsky.social/post/3mugtntowls2zDeveloping a new antibiotic is only half the race. 🌍 But it's equally important that treatments reach the countries and communities with the greatest need, without unnecessary delays. 💊At GARDP, we believe antibiotic innovation and access must go hand in hand in the fight against #AMR.01 Sep 2026 06:55 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mugtntowls2zhttps://bsky.app/profile/gardp.bsky.social/post/3mueagpzafk2tLearn how public-private partnerships help facilitate drug development, advance research, provide financing and share risks in this REVIVE Encyclopaedia video featuring Clara Maure from GARDP. 🎥 https://revive.gardp.org/resource/public-private-partnership-ppp/?cf=encyclopaedia #AMR #REVIVE31 Aug 2026 06:06 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mueagpzafk2thttps://bsky.app/profile/gardp.bsky.social/post/3mu4optovkk2fWhat would happen if antibiotics stopped working? In a recent interview with GARDP, Dr. Norio Ohmagari discusses the growing threat of AMR, the challenges facing antibiotic development and the importance of global collaboration. 🔗Read the full interview: https://gardp.org/healthcare-itself-may-cease-to-function/28 Aug 2026 06:00 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mu4optovkk2fhttps://bsky.app/profile/gardp.bsky.social/post/3mu2hyyoya223🎙️Join us for AMR Discussions Webinar - Breaking the resistance: Empowering the next generation of antimicrobial researchers. 📅3 Sept | 🕒15:00–16:00 CEST Explore the shortage of specialised antimicrobial researchers & solutions to attract & retain talent. 👉 https://register.gotowebinar.com/register/2981739652574190429?source=Bluesky27 Aug 2026 08:55 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mu2hyyoya223https://bsky.app/profile/gardp.bsky.social/post/3mtyai4rnps2o👶 A bigger response means putting children first Too often, children wait for evidence to guide antibiotic treatment. Together with @pentafoundation.bsky.social, we're helping close the evidence gap for children and ensure they are part of antibiotic development from the start.26 Aug 2026 11:35 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtyai4rnps2ohttps://bsky.app/profile/gardp.bsky.social/post/3mtxyxmkyq22jswissinfo.ch takes a closer look at the strategic collaboration between @dndi.org, @mmv.org and GARDP as the global health landscape changes. 🔗Read here: https://www.swissinfo.ch/eng/new-treatments/swiss-non-profit-drugmakers-team-up-as-funding-shrinks/9194683226 Aug 2026 09:20 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtxyxmkyq22jhttps://bsky.app/profile/gardp.bsky.social/post/3mtvmh4b7yc27On #WorldSepsisDay, join experts exploring how antimicrobial stewardship can strengthen neonatal care, improve antibiotic use and help address AMR. GARDP’s Justin Green will join the discussion. 📅 8 Sept | 3pm EAT | 1pm WAT | 1pm BST | 8am EDT 🔗 https://newborntoolkit.org/webinars/world-sepsis-day-webinar?back_action=/webinars?tab=upcoming [contains quote post or other embedded content]25 Aug 2026 10:31 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtvmh4b7yc27https://bsky.app/profile/gardp.bsky.social/post/3mtv5wukkuk27GARDP & the South African Medical Research Council recently convened experts in Cape Town to help shape GARDP's Strategic Plan 2027-31. The discussion focused on South African priorities for developing & improving access to much-needed antibiotic treatments in the region. @samrcza.bsky.social25 Aug 2026 06:11 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtv5wukkuk27https://bsky.app/profile/gardp.bsky.social/post/3mtq5skebzc2m⏳ One month to go until #GAMRIC2026! Join the global AMR community in Lisbon for three days of discussions on breakthroughs in therapeutics, diagnostics, vaccines and preventatives addressing AMR. 📍 Lisbon, Portugal 📅 22–24 September 🔗 www.gamric.org23 Aug 2026 06:25 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtq5skebzc2mhttps://bsky.app/profile/gardp.bsky.social/post/3mtl23i5njc2b🎙️ Join our AMR Discussions webinar on 3 Sept (14:30-15:30 CEST) As expert researchers leave or retire, how can we attract and retain the talent needed to secure the future of antibiotic development? 🔗Register: https://attendee.gotowebinar.com/register/2981739652574190429?source=Bluesky21 Aug 2026 05:35 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtl23i5njc2bhttps://bsky.app/profile/gardp.bsky.social/post/3mtgejvuc6s2o🌍 Since 2018, REVIVE has helped bring together researchers from clinical, industry and academic settings to share expert #AMR knowledge. 📚 Through a growing library of free resources, REVIVE supports early-stage antimicrobial researchers. 🌐Explore everything #REVIVE has to offer: revive.gardp.org19 Aug 2026 08:59 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtgejvuc6s2ohttps://bsky.app/profile/gardp.bsky.social/post/3mtdx5dd6dk2e📝 New in STAT: What if the global antibiotic crisis isn’t just about overuse, but underuse too? New research in @thelancet.com points to overuse in some parts of the world and underuse in others. Peter Beyer explores what this means for access and stewardship. 🔗 https://www.statnews.com/2026/08/18/antibiotic-underuse-overuse-resistance-aware/18 Aug 2026 09:54 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtdx5dd6dk2ehttps://bsky.app/profile/gardp.bsky.social/post/3mtazzznl222y📖Have you read GARDP's Annual Report 2025 yet? Read how GARDP is turning vision into reality, and why the journey is far from over. 🔗Read the report: https://gardp.org/annual-report-2025/ #AnnualReport #AMR #AntimicrobialResistance #GlobalHealth #GARDP17 Aug 2026 06:08 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mtazzznl222yhttps://bsky.app/profile/gardp.bsky.social/post/3mszjicoxdc2q#FungalAwarenessWeek2026 is almost here! Join REVIVE on 17 September for a webinar exploring recent advances to overcome pharmacokinetic & pharmacodynamic challenges in antifungal therapy. Hear from leading experts & take part in a live Q&A. 📅 Register: https://register.gotowebinar.com/register/754048829754636117?source=Bluesky14 Aug 2026 06:23 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mszjicoxdc2qhttps://bsky.app/profile/gardp.bsky.social/post/3msuhw2dpys2x🏆 NUZOLVENCE® (zoliflodacin) has been nominated for the 2026 Prix Galien USA Award for Best Pharmaceutical Product This first new antibiotic developed solely for gonorrhoea in decades is developed in a public-private partnership between GARDP and Innoviva Specialty Therapeutics tinyurl.com/jja4paej12 Aug 2026 06:12 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3msuhw2dpys2xhttps://bsky.app/profile/gardp.bsky.social/post/3msrwy2h4bs2yA new Letter to the Editor in the Journal of Translational Medicine welcomes the draft ICH E21 guideline and calls for action to close evidence gaps for pregnant and breastfeeding women. Congrats to Tammy Meyers, the Collaborative Group and @dndi.org. 📖Read: https://link.springer.com/article/10.1186/s12967-026-08509-z11 Aug 2026 06:03 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3msrwy2h4bs2yhttps://bsky.app/profile/gardp.bsky.social/post/3mspmsbhbos2o🦠 Last year, our campaign #ThisIsBig highlighted the scale of antimicrobial resistance. This year, we're focusing on what it takes to change its trajectory. 💥 AMR is BIG. Our response is BIGGER. Follow us as we spotlight our partnerships and how innovations can drive a bigger response to AMR.10 Aug 2026 07:56 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mspmsbhbos2o